Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.54 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.54 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 5/20 | 0.50 |
| ▸ | BLM | P54132 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | THPO | P40225 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminomethylamide SCHEMBL8299 | 1.00 | — | — | |
| Aminomethylamide SCHEMBL6367847 | 0.95 | — | — | |
| Aminomethylamide SCHEMBL1633398 | 0.95 | — | — | |
| Aminomethylamide SCHEMBL30585648 | 0.95 | — | — | |
| Aminomethylamide SCHEMBL3747901 | 0.95 | — | — | |
| Aminomethylamide SCHEMBL11065567 | 0.95 | — | — | |
| Aminomethylamide SCHEMBL28905000 | 0.95 | — | — | |
| Aminomethylamide SCHEMBL21981127 | 0.95 | — | — | |
| Aminomethylamide SCHEMBL22532762 | 0.95 | — | — | |
| Aminomethylamide SCHEMBL29085485 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114206332-B | 2,3, 5-Trisubstituted pyrazolo [1,5-A ] pyrimidine compounds | 艾库斯生物科学有限公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-110612100-B | Quinazoline-pyridine derivatives for the treatment of diseases associated with cancer | 艾库斯生物科学有限公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-110049767-B | Inhibitors of adenosine 5' -nucleotidase | 艾库斯生物科学有限公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-114206332-A | 2,3, 5-trisubstituted pyrazolo [1,5-A ] pyrimidine compounds | 艾库斯生物科学有限公司 | 2022-03-18 | — | — | CN | disclosed |
| US-20110286937-A1 | SYNTHETIC GLYCOLIPID-CONTAINING LIPOSOME | GIFU UNIVERSITY (JP) | 2011-11-24 | — | — | US | disclosed |
| EP-2255787-A1 | SYNTHETIC GLYCOLIPID-CONTAINING LIPOSOMES | Katayama Chemical Industries Co., Ltd. (JP) | 2010-12-01 | — | — | EP | disclosed |
| US-4601839-A | A-AMINOACETAMIDES | THE B. F. GOODRICH COMPANY (US) | 1986-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110286937-A1 | SYNTHETIC GLYCOLIPID-CONTAINING LIPOSOME | UGCG, SGMS2, CERT1 | OR51E2 3899/4885GLRA1 2055/4885SLC6A9 1393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.